APO Research, Inc.

APO RESEARCH · REPORT

Medical Radioisotopes

Selected research

Market Structure

Global Medical Radioisotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Medical Radioisotopes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Medical Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Medical Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Medical Radioisotopes include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen and Polatom, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Medical Radioisotopes market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Radioisotopes and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Radioisotopes revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Medical Radioisotopes market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Radioisotopes Segment by Company

NRG

IRE

ANSTO

NTP Radioisotopes

China National Nuclear Corporation

Rosatom

Nordion

Eckert & Ziegler Strahlen

Polatom

Medical Radioisotopes Segment by Type

Tc-99m

Cobalt-60

Iodine Radioisotopes

Medical Radioisotopes Segment by Application

Nuclear Therapy

Equipment Radioactive Source

Diagnosis

Others

Medical Radioisotopes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Radioisotopes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Medical Radioisotopes in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Radioisotopes industry.

Chapter 3: Detailed analysis of Medical Radioisotopes companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Radioisotopesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Radioisotopes Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Tc-99m Table 3. Key Players of Cobalt-60 Table 4. Key Players of Iodine Radioisotopes Table 4. Global Medical Radioisotopes Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Nuclear Therapy Table 6. Key Players of Equipment Radioactive Source Table 7. Key Players of Diagnosis Table 8. Key Players of Others Table 9. Global Medical Radioisotopes Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Medical Radioisotopes Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Medical Radioisotopes Market Share by Region (2021-2026) Table 12. Global Medical Radioisotopes Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Medical Radioisotopes Market Share by Region (2027-2032) Table 14. Medical Radioisotopes Industry Trends Table 15. Medical Radioisotopes Industry Drivers Table 16. Medical Radioisotopes Industry Opportunities and Challenges Table 17. Medical Radioisotopes Industry Restraints Table 18. Global Medical Radioisotopes Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Medical Radioisotopes Revenue Market Share by Company (2021-2026) Table 20. Global Medical Radioisotopes Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Medical Radioisotopes Key Company Head Office and Area Served Table 22. Global Medical Radioisotopes Company, Product Type & Application Table 23. Global Medical Radioisotopes Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Medical Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Medical Radioisotopes Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Medical Radioisotopes Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Medical Radioisotopes Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Medical Radioisotopes Revenue Market Share by Type (2021-2026) Table 30. Global Medical Radioisotopes Revenue Market Share by Type (2027-2032) Table 31. Global Medical Radioisotopes Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Medical Radioisotopes Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Medical Radioisotopes Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Medical Radioisotopes Revenue Market Share by Application (2021-2026) Table 35. Global Medical Radioisotopes Revenue Market Share by Application (2027-2032) Table 36. NRG Company Information Table 37. NRG Business Overview Table 38. NRG Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. NRG Medical Radioisotopes Product Portfolio Table 40. NRG Recent Development Table 41. IRE Company Information Table 42. IRE Business Overview Table 43. IRE Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. IRE Medical Radioisotopes Product Portfolio Table 45. IRE Recent Development Table 46. ANSTO Company Information Table 47. ANSTO Business Overview Table 48. ANSTO Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. ANSTO Medical Radioisotopes Product Portfolio Table 50. ANSTO Recent Development Table 51. NTP Radioisotopes Company Information Table 52. NTP Radioisotopes Business Overview Table 53. NTP Radioisotopes Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. NTP Radioisotopes Medical Radioisotopes Product Portfolio Table 55. NTP Radioisotopes Recent Development Table 56. China National Nuclear Corporation Company Information Table 57. China National Nuclear Corporation Business Overview Table 58. China National Nuclear Corporation Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. China National Nuclear Corporation Medical Radioisotopes Product Portfolio Table 60. China National Nuclear Corporation Recent Development Table 61. Rosatom Company Information Table 62. Rosatom Business Overview Table 63. Rosatom Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Rosatom Medical Radioisotopes Product Portfolio Table 65. Rosatom Recent Development Table 66. Nordion Company Information Table 67. Nordion Business Overview Table 68. Nordion Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Nordion Medical Radioisotopes Product Portfolio Table 70. Nordion Recent Development Table 71. Eckert & Ziegler Strahlen Company Information Table 72. Eckert & Ziegler Strahlen Business Overview Table 73. Eckert & Ziegler Strahlen Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Eckert & Ziegler Strahlen Medical Radioisotopes Product Portfolio Table 75. Eckert & Ziegler Strahlen Recent Development Table 76. Polatom Company Information Table 77. Polatom Business Overview Table 78. Polatom Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Polatom Medical Radioisotopes Product Portfolio Table 80. Polatom Recent Development Table 81. North America Medical Radioisotopes Market Size by Type (2021-2026) & (US$ Million) Table 82. North America Medical Radioisotopes Market Size by Type (2027-2032) & (US$ Million) Table 83. North America Medical Radioisotopes Market Size by Application (2021-2026) & (US$ Million) Table 84. North America Medical Radioisotopes Market Size by Application (2027-2032) & (US$ Million) Table 85. North America Medical Radioisotopes Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America Medical Radioisotopes Market Size by Country (2021-2026) Table 87. North America Medical Radioisotopes Market Size by Country (2027-2032) Table 88. Europe Medical Radioisotopes Market Size by Type (2021-2026) & (US$ Million) Table 89. Europe Medical Radioisotopes Market Size by Type (2027-2032) & (US$ Million) Table 90. Europe Medical Radioisotopes Market Size by Application (2021-2026) & (US$ Million) Table 91. Europe Medical Radioisotopes Market Size by Application (2027-2032) & (US$ Million) Table 92. Europe Medical Radioisotopes Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Europe Medical Radioisotopes Market Size by Country (2021-2026) Table 94. Europe Medical Radioisotopes Market Size by Country (2027-2032) Table 95. China Medical Radioisotopes Market Size by Type (2021-2026) & (US$ Million) Table 96. China Medical Radioisotopes Market Size by Type (2027-2032) & (US$ Million) Table 97. China Medical Radioisotopes Market Size by Application (2021-2026) & (US$ Million) Table 98. China Medical Radioisotopes Market Size by Application (2027-2032) & (US$ Million) Table 99. Asia Medical Radioisotopes Market Size by Type (2021-2026) & (US$ Million) Table 100. Asia Medical Radioisotopes Market Size by Type (2027-2032) & (US$ Million) Table 101. Asia Medical Radioisotopes Market Size by Application (2021-2026) & (US$ Million) Table 102. Asia Medical Radioisotopes Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Medical Radioisotopes Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Asia Medical Radioisotopes Market Size by Country (2021-2026) Table 105. Asia Medical Radioisotopes Market Size by Country (2027-2032) Table 106. South America, Middle East & Africa Medical Radioisotopes Market Size by Type (2021-2026) & (US$ Million) Table 107. South America, Middle East & Africa Medical Radioisotopes Market Size by Type (2027-2032) & (US$ Million) Table 108. South America, Middle East & Africa Medical Radioisotopes Market Size by Application (2021-2026) & (US$ Million) Table 109. South America, Middle East & Africa Medical Radioisotopes Market Size by Application (2027-2032) & (US$ Million) Table 110. South America, Middle East & Africa Medical Radioisotopes Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. South America, Middle East & Africa Medical Radioisotopes Market Size by Country (2021-2026) Table 112. South America, Middle East & Africa Medical Radioisotopes Market Size by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Medical Radioisotopes Product Image Figure 2. Global Medical Radioisotopes Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Medical Radioisotopes Market Share by Type: 2025 VS 2032 Figure 4. Tc-99m Image Figure 5. Cobalt-60 Image Figure 6. Iodine Radioisotopes Image Figure 7. Global Medical Radioisotopes Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Medical Radioisotopes Market Share by Application: 2025 VS 2032 Figure 9. Nuclear Therapy Image Figure 10. Equipment Radioactive Source Image Figure 11. Diagnosis Image Figure 12. Others Image Figure 13. Global Medical Radioisotopes Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 15. Global Medical Radioisotopes Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Medical Radioisotopes Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Medical Radioisotopes Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Medical Radioisotopes Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Medical Radioisotopes Revenue Market Share by Type (2021-2032) Figure 22. Global Medical Radioisotopes Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Medical Radioisotopes Revenue Market Share by Application (2021-2032) Figure 24. North America Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 25. North America Medical Radioisotopes Market Share by Type (2021-2032) Figure 26. North America Medical Radioisotopes Market Share by Application (2021-2032) Figure 27. North America Medical Radioisotopes Market Share by Country (2021-2032) Figure 28. United States Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 29. Canada Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 31. Europe Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 32. Europe Medical Radioisotopes Market Share by Type (2021-2032) Figure 33. Europe Medical Radioisotopes Market Share by Application (2021-2032) Figure 34. Europe Medical Radioisotopes Market Share by Country (2021-2032) Figure 35. Germany Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 36. France Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 38. Italy Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 39. Russia Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 41. China Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 42. China Medical Radioisotopes Market Share by Type (2021-2032) Figure 43. China Medical Radioisotopes Market Share by Application (2021-2032) Figure 44. Asia Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 45. Asia Medical Radioisotopes Market Share by Type (2021-2032) Figure 46. Asia Medical Radioisotopes Market Share by Application (2021-2032) Figure 47. Asia Medical Radioisotopes Market Share by Country (2021-2032) Figure 48. Japan Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 52. India Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 53. Australia Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Medical Radioisotopes Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Medical Radioisotopes Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Medical Radioisotopes Market Share by Country (2021-2032) Figure 58. Brazil Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 63. UAE Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 65. Chile Medical Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Tc-99m
  • Cobalt-60
  • Iodine Radioisotopes
Applications
  • Nuclear Therapy
  • Equipment Radioactive Source
  • Diagnosis
  • Others
Companies covered
  • NRG
  • IRE
  • ANSTO
  • NTP Radioisotopes
  • China National Nuclear Corporation
  • Rosatom
  • Nordion
  • Eckert & Ziegler Strahlen
  • Polatom

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Medical Radioisotopes Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Tc-99m
  5. 1.2.3 Cobalt-60
  6. 1.2.4 Iodine Radioisotopes
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Medical Radioisotopes Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Nuclear Therapy
  10. 1.3.3 Equipment Radioactive Source
  11. 1.3.4 Diagnosis
  12. 1.3.5 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Medical Radioisotopes Growth Trends by Region
  15. 1.5.1 Global Medical Radioisotopes Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Medical Radioisotopes Market Size by Region (2021-2026)
  17. 1.5.3 Medical Radioisotopes Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Medical Radioisotopes Market Dynamics
  1. 2.1 Medical Radioisotopes Industry Trends
  2. 2.2 Medical Radioisotopes Industry Drivers
  3. 2.3 Medical Radioisotopes Industry Opportunities and Challenges
  4. 2.4 Medical Radioisotopes Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Medical Radioisotopes Revenue by Company (2021-2026)
  2. 3.2 Global Medical Radioisotopes Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Medical Radioisotopes Key Company Head office and Area Served
  4. 3.4 Global Medical Radioisotopes Company, Product Type & Application
  5. 3.5 Global Medical Radioisotopes Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Medical Radioisotopes Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Medical Radioisotopes Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Medical Radioisotopes Tier 1, Tier 2, and Tier 3
4 Medical Radioisotopes Market by Type
  1. 4.1 Global Medical Radioisotopes Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Medical Radioisotopes Market Size by Type (2021-2032)
  3. 4.3 Global Medical Radioisotopes Market Size Share by Type (2021-2032)
5 Medical Radioisotopes Market by Application
  1. 5.1 Global Medical Radioisotopes Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Medical Radioisotopes Market Size by Application (2021-2032)
  3. 5.3 Global Medical Radioisotopes Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 NRG
  2. 6.1.1 NRG Company Information
  3. 6.1.2 NRG Business Overview
  4. 6.1.3 NRG Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 NRG Medical Radioisotopes Product Portfolio
  6. 6.1.5 NRG Recent Developments
  7. 6.2 IRE
  8. 6.2.1 IRE Company Information
  9. 6.2.2 IRE Business Overview
  10. 6.2.3 IRE Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 IRE Medical Radioisotopes Product Portfolio
  12. 6.2.5 IRE Recent Developments
  13. 6.3 ANSTO
  14. 6.3.1 ANSTO Company Information
  15. 6.3.2 ANSTO Business Overview
  16. 6.3.3 ANSTO Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 ANSTO Medical Radioisotopes Product Portfolio
  18. 6.3.5 ANSTO Recent Developments
  19. 6.4 NTP Radioisotopes
  20. 6.4.1 NTP Radioisotopes Company Information
  21. 6.4.2 NTP Radioisotopes Business Overview
  22. 6.4.3 NTP Radioisotopes Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 NTP Radioisotopes Medical Radioisotopes Product Portfolio
  24. 6.4.5 NTP Radioisotopes Recent Developments
  25. 6.5 China National Nuclear Corporation
  26. 6.5.1 China National Nuclear Corporation Company Information
  27. 6.5.2 China National Nuclear Corporation Business Overview
  28. 6.5.3 China National Nuclear Corporation Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 China National Nuclear Corporation Medical Radioisotopes Product Portfolio
  30. 6.5.5 China National Nuclear Corporation Recent Developments
  31. 6.6 Rosatom
  32. 6.6.1 Rosatom Company Information
  33. 6.6.2 Rosatom Business Overview
  34. 6.6.3 Rosatom Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Rosatom Medical Radioisotopes Product Portfolio
  36. 6.6.5 Rosatom Recent Developments
  37. 6.7 Nordion
  38. 6.7.1 Nordion Company Information
  39. 6.7.2 Nordion Business Overview
  40. 6.7.3 Nordion Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Nordion Medical Radioisotopes Product Portfolio
  42. 6.7.5 Nordion Recent Developments
  43. 6.8 Eckert & Ziegler Strahlen
  44. 6.8.1 Eckert & Ziegler Strahlen Company Information
  45. 6.8.2 Eckert & Ziegler Strahlen Business Overview
  46. 6.8.3 Eckert & Ziegler Strahlen Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Eckert & Ziegler Strahlen Medical Radioisotopes Product Portfolio
  48. 6.8.5 Eckert & Ziegler Strahlen Recent Developments
  49. 6.9 Polatom
  50. 6.9.1 Polatom Company Information
  51. 6.9.2 Polatom Business Overview
  52. 6.9.3 Polatom Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Polatom Medical Radioisotopes Product Portfolio
  54. 6.9.5 Polatom Recent Developments
7 North America
  1. 7.1 North America Medical Radioisotopes Market Size (2021-2032)
  2. 7.2 North America Medical Radioisotopes Market Size by Type
  3. 7.2.1 North America Medical Radioisotopes Market Size by Type (2021-2026)
  4. 7.2.2 North America Medical Radioisotopes Market Size by Type (2027-2032)
  5. 7.2.3 North America Medical Radioisotopes Market Share by Type (2021-2032)
  6. 7.3 North America Medical Radioisotopes Market Size by Application
  7. 7.3.1 North America Medical Radioisotopes Market Size by Application (2021-2026)
  8. 7.3.2 North America Medical Radioisotopes Market Size by Application (2027-2032)
  9. 7.3.3 North America Medical Radioisotopes Market Share by Application (2021-2032)
  10. 7.4 North America Medical Radioisotopes Market Size by Country
  11. 7.4.1 North America Medical Radioisotopes Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Medical Radioisotopes Market Size by Country (2021-2026)
  13. 7.4.3 North America Medical Radioisotopes Market Size by Country (2027-2032)
  14. 7.4.4 North America Medical Radioisotopes Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Medical Radioisotopes Market Size (2021-2032)
  2. 8.2 Europe Medical Radioisotopes Market Size by Type
  3. 8.2.1 Europe Medical Radioisotopes Market Size by Type (2021-2026)
  4. 8.2.2 Europe Medical Radioisotopes Market Size by Type (2027-2032)
  5. 8.2.3 Europe Medical Radioisotopes Market Share by Type (2021-2032)
  6. 8.3 Europe Medical Radioisotopes Market Size by Application
  7. 8.3.1 Europe Medical Radioisotopes Market Size by Application (2021-2026)
  8. 8.3.2 Europe Medical Radioisotopes Market Size by Application (2027-2032)
  9. 8.3.3 Europe Medical Radioisotopes Market Share by Application (2021-2032)
  10. 8.4 Europe Medical Radioisotopes Market Size by Country
  11. 8.4.1 Europe Medical Radioisotopes Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Medical Radioisotopes Market Size by Country (2021-2026)
  13. 8.4.3 Europe Medical Radioisotopes Market Size by Country (2027-2032)
  14. 8.4.4 Europe Medical Radioisotopes Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Medical Radioisotopes Market Size (2021-2032)
  2. 9.2 China Medical Radioisotopes Market Size by Type
  3. 9.2.1 China Medical Radioisotopes Market Size by Type (2021-2026)
  4. 9.2.2 China Medical Radioisotopes Market Size by Type (2027-2032)
  5. 9.2.3 China Medical Radioisotopes Market Share by Type (2021-2032)
  6. 9.3 China Medical Radioisotopes Market Size by Application
  7. 9.3.1 China Medical Radioisotopes Market Size by Application (2021-2026)
  8. 9.3.2 China Medical Radioisotopes Market Size by Application (2027-2032)
  9. 9.3.3 China Medical Radioisotopes Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Medical Radioisotopes Market Size (2021-2032)
  2. 10.2 Asia Medical Radioisotopes Market Size by Type
  3. 10.2.1 Asia Medical Radioisotopes Market Size by Type (2021-2026)
  4. 10.2.2 Asia Medical Radioisotopes Market Size by Type (2027-2032)
  5. 10.2.3 Asia Medical Radioisotopes Market Share by Type (2021-2032)
  6. 10.3 Asia Medical Radioisotopes Market Size by Application
  7. 10.3.1 Asia Medical Radioisotopes Market Size by Application (2021-2026)
  8. 10.3.2 Asia Medical Radioisotopes Market Size by Application (2027-2032)
  9. 10.3.3 Asia Medical Radioisotopes Market Share by Application (2021-2032)
  10. 10.4 Asia Medical Radioisotopes Market Size by Country
  11. 10.4.1 Asia Medical Radioisotopes Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Medical Radioisotopes Market Size by Country (2021-2026)
  13. 10.4.3 Asia Medical Radioisotopes Market Size by Country (2027-2032)
  14. 10.4.4 Asia Medical Radioisotopes Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Medical Radioisotopes Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Medical Radioisotopes Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Medical Radioisotopes Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Medical Radioisotopes Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Medical Radioisotopes Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Medical Radioisotopes Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Medical Radioisotopes Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Medical Radioisotopes Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Medical Radioisotopes Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Medical Radioisotopes Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Medical Radioisotopes Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Medical Radioisotopes Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Medical Radioisotopes Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Medical Radioisotopes Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.